To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.

Bill 118 hr 4096, also known as the Medicaid Antipsychotic Monitoring Act, aims to make changes to title XIX of the Social Security Act in order to broaden the scope of Medicaid State programs. Specifically, this bill seeks to extend the application of Medicaid State programs to monitor the usage of antipsychotic medications to all Medicaid beneficiaries.

Currently, Medicaid State programs only monitor the usage of antipsychotic medications for certain Medicaid beneficiaries. However, this bill proposes that all Medicaid beneficiaries should be included in these monitoring programs. This is important because antipsychotic medications can have serious side effects and should be closely monitored to ensure they are being used appropriately and safely.

By expanding the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries, this bill aims to improve the overall quality of care for individuals receiving Medicaid benefits. It will help to ensure that these medications are being used effectively and safely, ultimately leading to better health outcomes for Medicaid beneficiaries. Overall, the Medicaid Antipsychotic Monitoring Act is a significant piece of legislation that seeks to enhance the monitoring of antipsychotic medications for Medicaid beneficiaries. It underscores the importance of ensuring the safe and appropriate use of these medications for individuals receiving Medicaid benefits.